Figure 9 | Scientific Reports

Figure 9

From: Forecasting of potential anti-inflammatory targets of some immunomodulatory plants and their constituents using in vitro, molecular docking and network pharmacology-based analysis

Figure 9

2D and 3D interaction diagrams of: (A) Silibinin in the active site of RAC-alpha serine/threonine-protein kinase (PBD ID 3O96) (B) Luteolin in the active site of prostaglandin endoperoxide synthase 2 (PDB ID 5F1A) and (C) Apigenin in the active site of tumor suppressor protein TP53 (PDB ID 2VUK).

Back to article page